Investors traded in a negative mood on Monday amid a deterioration of the health crisis in the EU and the United States, following one of the best weeks for stock markets since November.
Búsqueda en Caixabank Research
Resultados de la búsqueda
2584 resultados para tourism report
Financial markets closed the first week of 2021 on a strong note as both European and U.S. stock markets posted their strongest weekly gains since November.
Investors traded in a risk-on mood as markets head into the holiday period. Yesterday, sentiment was supported by news that the UK and the EU are on the verge of unveiling a trade deal (an announcement is expected today).
Investors traded cautiously in yesterday's session. European stocks rebounded from Monday's sell-off while most other benchmarks were mixed.
A new variant of the coronavirus in the U.K. triggered a global sell-off yesterday. The new variant, which is said to be up to 70% more infectious, sent stocks lower across the world.
Markets ended the week with a volatile 'quadruple witching' session (index and single stock options and futures expired simultaneously).
In yesterday's session investors continued trading with moderate optimism. Despite the evolution of the pandemic and the weekly 23k increase in initial unemployment claims in the US, hopes that the fiscal stimulus would be finally unveiled led the main US stock indices to new record highs.
The accommodative monetary policy stance confirmed in yesterday's Federal Reserve's meeting and the better-than-expected December flash PMIs in the euro area kept optimism among investors. In particular, the manufacturing indices were expected to fall but managed to increase, and the services indices rose but remained below 50.
Investor sentiment remained moderately optimistic in yesterday's session despite the evolution of the pandemic.
Investors started the week with fresh optimism as the EU and the UK are set to continue negotiating to reach a deal before the transition period ends by December 31st.
In the last session of the week, investor sentiment worsened as uncertainty over the fiscal stimulus in the US rose and the EU-UK trade negotiations seemed to be heading towards a no-deal brexit.
Investors continued to trade cautiously in yesterday's session as EU policymakers relaunched Europe's economic stimulus and amid signals that U.S. activity is losing steam (initial unemployment claims jumped to a 3-month high). Stock markets were mixed, the USD weakened and sovereign yields were little changed.
Markets ended mixed after a more cautious session. Volatility nudged up and European and EM stocks were mixed, while weakness in some technology shares dragged down U.S. stocks.
Investors traded in a mixed mood in the first two sessions of the week. EM stocks were mixed and European equities nudged down, while U.S. stocks continued to advance on the back of health equities (the FDA signaled it will give the go-ahead to the Pfizer-BioNTech vaccine soon) and on greater hopes for a new fiscal package.
Investors exhibited a mixed mood in yesterday's session as they pondered on increasing infections and tighter restrictions. Volatility edged up and stocks advanced moderately across Europe and EM, while U.S. equities declined in spite of Pfizer's announcement that it will apply for the FDA emergency authorization of its vaccine within days.
Investors traded with a risk-on mood in yesterday's session amid the formal start of Joe Biden's transition into the White House.
Economic sentiment data and new advances in a vaccine treatment for COVID-19 were the main drivers of a mixed session in financial markets. On the one hand, the University of Oxford and AstraZeneca Plc said that their vaccine prevented 70% of the participants from falling ill. This effectiveness rises to 90% with an alternative treatment.
Financial markets were mixed in the last session of the week amid hopes for a COVID-19 vaccine, the advance of the second wave and growing tensions between the US Treasury and the Federal Reserve.
Last Friday, markets ended one of their best weeks since summer as economically-sensitive assets regained momentum on the back of positive COVID-19 vaccine developments.
This past week's stock market vaccine rally went into reverse on Thursday as Covid-19 cases and deaths climbed across the world.